Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 262 publications
Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma.
Journal: Future oncology (London, England)
Published: July 14, 2026
Dual target combination therapy demonstrates promise in extramedullary myeloma.
Journal: Translational cancer research
Published: April 17, 2026
Improving MM outcomes with bispecific antibody combinations.
Journal: Blood
Published: December 11, 2025
Impact of body mass index on the prognosis of patients with newly diagnosed multiple myeloma.
Journal: Blood advances
Published: August 06, 2025
Sex differences in the clinical presentation of patients with newly diagnosed multiple myeloma.
Journal: Cancer
Published: July 28, 2025
Genomic features do not account for differences in multiple myeloma risk by ancestry.
Journal: Blood cancer discovery
Published: July 15, 2025
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis.
Journal: European journal of haematology
Published: July 14, 2025
Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 25, 2025
Operational considerations for the running of an NHS faecal microbiota transplant service.
Journal: The Journal of hospital infection
Published: June 12, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 09, 2025
Last Updated: 09/26/2026